Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lai

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Elife|November 17, 2016
The genome of the crustacean <i>Parhyale hawaiensis,</i> a model for animal development, regeneration, immunity and lignocellulose digestionDamian Kao, Alvina G Lai, Evangelia Stamataki, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Celine Bonnefous, Jackaline D Julien, et al.
Nature Communications|January 24, 2019
The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replicationXiaodong Zhuang, Andrea Magri, Michelle Hill, et al.
BMJ Open|November 18, 2020
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort studyAlvina G Lai, Laura Pasea, Amitava Banerjee, et al.
Cancer Research|April 8, 2024
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced MutationsChen-Yang Huang, Nanhai Jiang, Meixin Shen, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
European Journal of Preventive Cardiology|February 21, 2021
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemicAmitava Banerjee, Suliang Chen, Laura Pasea, et al.
Nature Biotechnology|February 16, 2005
A small molecule-kinase interaction map for clinical kinase inhibitorsMiles A Fabian, William H Biggs, Daniel K Treiber, et al.
BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
Journal of Medicinal Chemistry|December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600EMartin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Elife|November 17, 2016
The genome of the crustacean <i>Parhyale hawaiensis,</i> a model for animal development, regeneration, immunity and lignocellulose digestionDamian Kao, Alvina G Lai, Evangelia Stamataki, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Celine Bonnefous, Jackaline D Julien, et al.
Nature Communications|January 24, 2019
The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replicationXiaodong Zhuang, Andrea Magri, Michelle Hill, et al.
BMJ Open|November 18, 2020
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort studyAlvina G Lai, Laura Pasea, Amitava Banerjee, et al.
Cancer Research|April 8, 2024
Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced MutationsChen-Yang Huang, Nanhai Jiang, Meixin Shen, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
European Journal of Preventive Cardiology|February 21, 2021
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemicAmitava Banerjee, Suliang Chen, Laura Pasea, et al.
Nature Biotechnology|February 16, 2005
A small molecule-kinase interaction map for clinical kinase inhibitorsMiles A Fabian, William H Biggs, Daniel K Treiber, et al.
BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
Journal of Medicinal Chemistry|December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600EMartin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Pageof 15